Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics were added as related topics on the study page.
    Difference
    0.1%
    Check dated 2026-03-15T04:38:20.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T02:45:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added. Lung cancer and related topics (MedlinePlus Genetics) and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-14T12:44:10.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor update to the revision metadata.
    Difference
    0.0%
    Check dated 2026-02-07T06:50:22.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added related topics in the Related topics section: Lung cancer and MedlinePlus Genetics; no changes to the core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-31T07:22:29.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Cosmetic UI/text updates include a glossary toggle, capitalization adjustments in labels, and a new revision/version label. They do not modify core study details, eligibility criteria, outcomes, or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-24T04:21:34.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.